Clinical Trials Browser

INDUSTRY × Interventional × Neuroma, Acoustic × Clear all

Neuroma, Acoustic, Hearing Loss

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT02948790 2021-10-20

NeuriStim

Phase NA Completed

17 enrolled

CNS

Hearing Loss, Sensorineural, Neuroma, Acoustic

Clinical Trials

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NeuriStim